Comparison of cell-surface TFPIalpha and beta.

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Tissue factor pathway inhibitor (TFPI) is primarily synthesized by endothelial cells.
• Alternative mRNA splicing produces two TFPI isoforms: TFPIalpha and TFPIbeta.
• Both isoforms can anchor to the cell surface via glycosylphosphatidyl-inositol (GPI)-mediated mechanisms.

Purpose of the Study:

• To compare the structural characteristics and functional properties of TFPIalpha and TFPIbeta.
• To investigate the glycosylation patterns and cellular activities of the two TFPI forms.

Main Methods:

• Differential glycosidase treatments were used to analyze TFPI isoform glycosylation.
• mRNA and protein synthesis of TFPI isoforms were assessed in ECV304 cells stimulated with inflammatory cytokines.
• Small interfering RNA (siRNA) was employed to generate cell lines with reduced TFPIalpha or TFPIbeta expression.
• Cell-surface TFPI activity was quantified using a chromogenic assay measuring FXa activation inhibition.

Main Results:

• Deglycosylation studies revealed TFPIbeta has greater sialylation of O-linked carbohydrates compared to TFPIalpha, explaining their differing molecular masses.
• Inflammatory stimuli (IL-1beta, LPS, TNFalpha) did not alter mRNA or protein levels of either TFPI form.
• TFPIalpha constituted 80% of surface-bound TFPI, but TFPIbeta accounted for the majority of cellular inhibitory activity against FVIIa/TF.

Conclusions:

• TFPIalpha and TFPIbeta exhibit distinct glycosylation profiles and functional contributions to cell surface TFPI activity.
• TFPIbeta plays a more significant role in inhibiting the FVIIa/TF complex, suggesting specialized functions.
• The findings indicate potential distinct roles for TFPIalpha and TFPIbeta beyond their shared function in the coagulation cascade.